Clinical Trials Logo

Bilateral Vestibular Deficiency clinical trials

View clinical trials related to Bilateral Vestibular Deficiency.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT04070937 Recruiting - Clinical trials for Hearing Loss, Sensorineural

Correlation of Radiological Lesions With Vestibular Function in Patients With Bilateral Vestibulopathy

Start date: September 1, 2019
Phase:
Study type: Observational [Patient Registry]

In 2014 radiologic lesions were detected at one or more semicircular canals using CT and MR imaging of temporal bone in subjects carrying the p.P51S mutation in COCH. These lesions are believed to present at more advanced stages of the hearing and vestibular deterioration. Since then, other authors have described similar lesions in advanced non-genetic hearing and vestibular impairment as well. The purpose of this study is therefore to assess the radiologic investigation using CT and MR imaging of temporal bone to all subjects presenting with bilateral vestibulopathy, using the Barany criteria, compared to the p.P51S population.

NCT ID: NCT04066270 Recruiting - Clinical trials for Hearing Loss, Sensorineural

Inventory of Radiological and Vestibular Function in Cochlear Implant Candidates

Start date: September 1, 2019
Phase:
Study type: Observational [Patient Registry]

In 2014 radiological lesions at one or more semicircular canals (SCC) were described using CT & MR imaging in subjects presenting advanced hearing and vestibular deterioration caused by the p.P51S mutation in COCH. Similar lesions were also described in other non-genetic advanced hearing and vestibular deterioration as well. With this prospective observational study it is the purpose to inventory imaging results of candidates for cochlear implantation which are routinely performed during the preoperative work up, since these patient present severe hearing impairment at both ears. A considerable part of them might present vestibular deterioration as well. It is the purpose to detect possible presence of these SCC lesions on CT and MR in this population and the prevalence of these lesions compared to DFNA9 patients.